Literature DB >> 8097606

Substitution mutations at the putative catalytic triad of the poliovirus 3C protease have differential effects on cleavage at different sites.

K M Kean1, M T Howell, S Grünert, M Girard, R J Jackson.   

Abstract

Picornavirus 3C proteases are substrate-specific cysteine proteases, proposed to be homologous to the trypsin/chymotrypsin-like serine proteases on the basis of structural predictions. Substitutions at the putative active-site residues (Glu71 and Cys147) of the poliovirus 3C protease did not completely abolish proteolytic processing in vitro. The activity of mutated 3C proteases was in the following hierarchy: Glu71-Cys147 (wild type) > Asp71-Cys147 > Glu71-Ser147 > Gln71-Cys147 > Asp71-Ser147 > Gln71-Ser147 (inactive at all sites). Such mutations had differential effects on cleavage at different sites of the poliovirus polyprotein. Cleavage within the P1 region of the polyprotein was the most defective, at the 1ABC/VP1 junction and particularly at the VP0/VP3 junction. Cleavage at the 3AB/3CD and 2B/2C junctions was less affected by the mutations, and the P2/P3 and 2A/2BC junctions were cleaved efficiently by all mutants except Gln71-Ser147. All the 3C mutants gave negative results in infectivity and replication assays after transfection, indicating that mutation of Glu71 or Cys147 virtually abolishes viral replication, irrespective of the efficiency of processing of the nonstructural part of the polyprotein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097606     DOI: 10.1006/viro.1993.1268

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

Review 1.  Protease inhibitors as antiviral agents.

Authors:  A K Patick; K E Potts
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

2.  In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.

Authors:  A K Patick; S L Binford; M A Brothers; R L Jackson; C E Ford; M D Diem; F Maldonado; P S Dragovich; R Zhou; T J Prins; S A Fuhrman; J W Meador; L S Zalman; D A Matthews; S T Worland
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 3.  Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions.

Authors:  A G Porter
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.

Authors:  Amy K Patick; Mary A Brothers; Fausto Maldonado; Susan Binford; Oscar Maldonado; Shella Fuhrman; Annkatrin Petersen; George J Smith; Leora S Zalman; Leigh Ann Burns-Naas; Jonathan Q Tran
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Viral precursor protein P3 and its processed products perform discrete and essential functions in the poliovirus RNA replication complex.

Authors:  Allyn Spear; Sushma A Ogram; B Joan Morasco; Lucia Eisner Smerage; James B Flanegan
Journal:  Virology       Date:  2015-08-21       Impact factor: 3.616

6.  Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus.

Authors:  M E Piccone; M Zellner; T F Kumosinski; P W Mason; M J Grubman
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  Characterization in vitro of an autocatalytic processing activity associated with the predicted 3C-like proteinase domain of the coronavirus avian infectious bronchitis virus.

Authors:  K W Tibbles; I Brierley; D Cavanagh; T D Brown
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Viral cysteine proteinases.

Authors:  Alexander E Gorbalenya; Eric J Snijder
Journal:  Perspect Drug Discov Des       Date:  1996
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.